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Ⅰ. Abstract 
 Mesenchymal stem cells (MSCs) are among the most promising sources of 
stem cells for regenerative medicine. However, their range of differentiation ability is 
very limited. MSCs readily differentiate into osteoblasts, chondrocytes, and adipocytes 
in vitro, but do not differentiate into cells of other tissues, such as cardiomyocytes with 
high efficiency. In this study, we attempted to determine prospective cell surface 
markers of human MSCs that readily differentiate into cardiomyocytes. The 
cardiomyogenic differentiation potential and the expression of cell surface markers 
involved in heart development were analyzed using various immortalized human MSC 
lines, and MSCs with high expression of N-cadherin showed a higher probability of 
differentiation into beating cardiomyocytes. The differentiated cardiomyocytes 
expressed terminally differentiated cardiomyocyte-specific markers such as α-actinin, 
cardiac troponin T, and connexin-43. A similar correlation was observed with primary 
human MSCs derived from bone marrow and adipose tissue. Moreover, 
N-cadherin-positive MSCs isolated using N-cadherin antibody-conjugated magnetic 
beads showed an apparently higher capacity for differentiation into cardiomyocytes than 
did the N-cadherin-negative population. Gene ontology analysis of global gene 
expression in these populations suggested that N-cadherin-positive MSCs selectively 
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up-regulated nuclear proteins involved in transcription. Results of quantitative 
polymerase chain reaction (qPCR) analyses demonstrated that the N-cadherin-positive 
population expressed significantly elevated messenger ribonucleic acid (mRNA) levels 
of cardiomyogenic progenitor-specific transcription factor genes, including Nkx2.5, 
Hand1, and GATA4, and pluripotency-related genes such as Pou5f1 (Oct4), Sall4, and 
Nanog. Our results suggest that N-cadherin is a novel prospective cell surface marker of 
human MSCs that show a better ability for cardiomyocyte differentiation; these MSCs 
are characterized by an up-regulated expression of transcription factors specific to 
cardiomyogenic progenitors. 
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Ⅱ. Abbreviations 
 
APC: allophycocyanin 
 
ASCs: adipose-derived stem cells  
 
BMSCs: bone marrow-derived MSCs  
 
Cn43: connexin-43  
 
CPCs: cardiac progenitor cells  
 
cTnT: cardiac troponin T  
 
DMEM: Dulbecco’s Eagle Medium  
 
ECL: Enhanced chemiluminescence  
 
EDTA: ethylenediaminetetraacetic acid  
 
EGFP: enhanced green fluorescent protein  
 
EGM: endothelial cells growth media  
 
ES: embryonic stem  
 
FCS: fetal calf serum  
 
GM-CSF: granulocyte-macrophage colony-stimulating factor  
 
HEK: Human embryonic kidney  
 
HUVEC: Human umbilical vein endothelial cells  
 
iPS: induced pluripotent stem  
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LVEF: left ventricular ejection fraction  
 
MACS: magnetic cell sorting  
 
MI: myocardial infarction  
 
MSCs: Mesenchymal stem cells  
 
Oct4: Pou5f1  
 
PBS: phosphate-buffered saline  
 
Pdgfrα: Platelet-derived growth factor receptor α  
 
PI: propidium iodide  
 
qPCR: Quantitative polymerase chain reaction  
 
RNA: ribonucleic acid  
 
Reverse Transcription: RT  
 
TBS: Tris-buffered saline  
 
VCAM-1: vascular cell adhesion molecule 1  
 
VEGFR: vascular endothelial growth factor receptor  
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Ⅲ. Introduction 
Ⅲ-1. Cardiac disease 
 Myocardial infarction (MI) caused by atherosclerosis of the coronary artery 
induces heart failure with high mortality. Atherosclerotic plaques lead to coronary artery 
stenosis and a reduction in the blood flow rate, thereby contributing to cardiac ischemia 
and necrosis. The injured cardiomyocytes are replaced by fibroblasts; this then leads to 
fibrosis. The injured left ventricle undergoes progressive chamber dilation. Because the 
myocardium has very limited regeneration ability, an injured heart cannot be repaired. 
Heart transplantation is currently considered the most effective treatment for severe 
heart failure. Although artificial hearts can be used until heart transplantation is possible, 
the current devices are not suitable for long-term use, and antithrombogenicity, 
biocompatibility, reliability, and durability of these devices need to be improved. 
Another serious concern for the clinical application of this methodology is the limited 
number of donors for heart transplantation. Therefore, stem cell therapy is expected to 
be an alternative regenerative medicine for heart failure.  
 
Ⅲ-2. Stem cell therapy for cardiac disease 
 Some types of stem cells can be considered useful for cardiac regeneration in 
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clinical trials. Human embryonic stem (ES) cells can differentiate into cardiomyocytes 
when exposed to activin A and bone morphogenic protein 4. (Laflamme et al., 2007). 
ES cells are pluripotent cells derived from the inner cell mass of blastocyst-stage 
embryos therefore these are not the optimal choice for clinical application. Human 
dermal fibroblast can be induced to become pluripotens stem cells by retroviral 
transduction of four transcription factors, viz., OCT3/4, SOX2, c-MYC, and KLF4 
(Takahashi et al., 2007). These induced pluripotent stem (iPS) cells circumvent many of 
the ethical issues surrounding ES cells. However, generating large numbers of 
autologous cardiomyocytes within a therapeutic time-frame remains challenging. 
Intramyocardial injections of skeletal myoblasts result in arrhythmias occurred (Leobon, 
2003). Because of these discouraging results, a decline in skeletal myoblast studies has 
been observed in recent years. Cardiac progenitor cells (CPCs) have also been used in 
clinical trials. These cells can be isolated from cardiac tissue obtained during heart 
surgery or by endocardial biopsy. Results from one of the trials demonstrated a 12.3% 
improvement in left ventricular ejection fraction (LVEF) in patients at 1 year after 
intracoronary injection of autologous c-kit
+
, lineage– CPCs following after MI (Bolli et 
al. 2011). MSCs have also been shown to be suitable candidates to repair cardiac injury 
post-MI. Under appropriate stimulation, MSCs can differentiate into myocytes, 
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endothelial cells, and smooth muscle cells in the infarcted heart (Kajstura et al., 2005). 
MSCs have been shown to differentiate into various cell types, including osteoblasts, 
chondrocytes, adipocytes, neurons, and skeletal and cardiac muscle cells in vitro. 
Results from recent studies have suggested that the delivery of adult MSCs into 
ischemic tissue augments the recovery of cardiac function after ischemia in vivo (Chen 
et al., 2004). However, the effects induced by MSCs were only effectual immediately 
after acute MI. Moreover, the successful differentiation of transplanted MSCs in vivo 
was quite infrequent, and the rarely observed differentiated cells in host tissues were 
mainly produced by cell fusion between the injected MSCs and differentiated host cells 
(Nygren et al., 2004). Therefore, the beneficial effects of MSCs may be attributed to the 
paracrine effects of various trophic factors transiently secreted by the injected stem cells 
(Caplan et al., 2011). These results suggest that improvements in the differentiation 
abilities of MSCs and their successful engraftment could be beneficial for effective 
treatment of heart failure.  
 
Ⅲ-3. Objective of this study and research plan 
MSCs can differentiate into many different cell lineages. However the 
efficiecny of their differentiation into cardiomyocytes is very low (Shiota et al., 2007; 
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Wakitani et al., 1995; Makino et al. 1999). To overcome this problem, we tried to 
determine prospective cell surface markers that could be used to isolate human MSCs 
with higher cardiomyogenic differentiation potential.  
During early embryogenesis, heart development can be monitored by the 
expression of a homeobox-containing transcription factor, Nkx2.5, which is expressed 
in the cardiomyogenic mesoderm at E7.5 in mouse embryos (Lints et al., 1993). The 
Nkx2.5-positive progenitor cells have a bi-potential character, and they subsequently 
differentiate into both cardiac and smooth muscle cells (Wu et al., 2006). Another 
transcription factor, Isl-1, which has two N-terminal LIM domains and one C-terminal 
homeodomain, is expressed in the splanchnic mesoderm at a similar stage (E7.5) (Cai et 
al., 2003). Isl-1-positive progenitors are tri-potential progenitor cells, and they 
differentiate into cardiomyocytes, endothelial cells, and smooth muscle cells (Moretti A. 
et al., 2006, Laugwitz et al., 2005). 
Flk1, a vascular endothelial growth factor receptor (VEGFR) 2, has been 
reported to be prospective cell surface marker of cardiomyocyte progenitor cells during 
heart development (Kattman et al., 2006, Yamashita et al., 2005, Ema et al., 2006). Flk1 
is expressed in the progenitors of multiple mesodermal lineages, including cardiac, 
endothelial, and vascular smooth muscle cells (Kattman et al., 2006). c-Kit (CD117 
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antigen) is a transmembrane tyrosine kinase receptor for stem-cell factor, and is used as 
a cell surface marker of hematopoietic progenitors, melanocytes, mast cells, and 
spermatogonial stem cells. c-Kit is also required for terminal differentiation of 
cardiomyocytes (Li et al., 2008). Recent research has suggested that c-kit could be a 
putative cell surface marker of cardiomyogenic progenitor cells in the neonatal heart 
(Tallini et al., 2009). 
A Ca
2+
-dependent cell-cell adhesion molecule (Figure 1), N-cadherin is also 
expressed on cardiomyocyte progenitor cells during mouse development (Figure 1). 
N-Cadherin expression is observed in the precardiac mesoderm at E8.5 in mice and 
continues to be expressed in the whole heart during development. N-Cadherin-knockout 
mice die by E10 because of defects in the primitive heart. Although myocardial tissue 
was initially formed in the knockout mouse embryos, the myocytes subsequently 
became dissociated, and the heart tube failed to develop (Radice et al., 1997).  
In this study, we studied cell surface markers of human MSCs that have a high 
ability to differentiate into cardiomyocytes. We show that N-cadherin is a prospective 
cell surface marker of MSCs with high cardiomyogenic potential. 
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Ⅳ. Materials and methods 
Ⅳ-1. Cells used in this study 
 Human MSC lines, namely, UE7T-13 (JCRB1154), UE6E7T-11 (JCRB1149), 
UBE6T-15 (JCRB1159), UE6E7T-12 (JCRB1151), UE7T-9 (JCRB1147), and 
UE6E7T-2 (JCRB1133), were obtained from the Japanese Collection of Research 
Bioresources Cell Bank (Osaka, Japan). These cell lines were immortalized by 
retrovirus gene transfer of a combination of bmi-1, E6, E7, and/or TERT genes to human 
bone marrow stromal cells harvested from a 91-year-old woman. The EPC-214 cell line 
was similarly immortalized at the National Research Institute for Child Health and 
Development (NRICHD), Tokyo, Japan. These cells were maintained in Dulbecco’s 
Eagle Medium (DMEM) with high glucose (Wako) supplemented with 10% fetal calf 
serum (FCS; Roche). ANP0425 and 0607NC cells derived from human bone marrow 
were obtained from Dr. Ohgushi (National Institute of Advanced Industrial Science and 
Technology, Hyougo, Japan). MSC-R36_2 cells, MSC-R36_3 cells, and Yub623 cells 
were obtained from the RIKEN BRC Cell Bank (Ibaraki, Japan). KN-SC (KN) cells, 
MY-SC (MY) cells, and NN-SC (NN) cells were prepared at the Research Institute 
National Center for Global Health and Medicine (NCGM), Tokyo, Japan. 
Adipose-derived stem cells (ASCs), including 09-036 (36) cells, 10-008 (8) cells, 
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05-055 (55) cells, and 05-076 (76) cells, were prepared at the University of Tokyo, 
School of Medicine, Tokyo, Japan. Other human ASCs were purchased from Invitrogen. 
For MSCs obtained from adipose tissue, all samples except KN-SC were obtained from 
women aged 22–45 years (KN-SC was derived from the adipose tissue of a 41-year-old 
man). All of these primary cells were maintained in MesenPRO RS Basal Medium 
supplemented with MesenPRO RS Growth Supplement (GIBCO). Cells were 
maintained in a humidified incubator at 37 °C with an atmosphere of 5% CO2. All the 
experiments using human materials were approved by the Human Ethics Committee at 
AIST, NRICHD, NCGM, and the University of Tokyo. Human umbilical vein 
endothelial cells (HUVEC) were cultured in RPMI-1640 medium supplemented with 
endothelial cells growth media (EGM)-2 SingleQuots (LONZA) and 
penicillin/streptomycin (Wako). TF-1 cells were cultured in RPMI-1640 supplemented 
with 10% FCS, 2 ng/mL rh granulocyte-macrophage colony-stimulating factor 
(GM-CSF), and penicillin/streptomycin (Wako). Human embryonic kidney (HEK) 
293FT cells were cultured in DMEM medium supplemented with 10% FCS, 2mM 
L-glutamine, 100μM Non-Essential Amino Acids and penicillin/streptomycin (Wako). 
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Ⅳ-2 Preparation of mouse fetal cardiomyocytes 
Fetal cardiomyocytes were obtained from the hearts of fetal ICR mice on 
gestation day 16.5. The fetal hearts were cut into small pieces and washed with 
phosphate-buffered saline (PBS). They were incubated with 0.15% trypsin and 0.012% 
ethylenediaminetetraacetic acid (EDTA) in PBS at 37 °C for 10 min under gentle 
stirring. The supernatant containing the dissociated cardiomyocytes was mixed with 
DMEM supplemented with 10% FCS and centrifuged at 1,000rpm (180g) for 5 min. 
The pellet was then re-suspended in 10 mL of DMEM with 10% FCS and incubated in a 
glass dish for 1 h to remove fibroblasts. The floating cardiomyocytes were collected and 
re-plated at 5 × 10
5
/cm
2
 on gelatin-coated glass bottom dishes (Asahi Techno Glass). All 
the experiments using animals were performed under the guidelines established by the 
University of Tsukuba Animal Use and approved by the Animal Experiment Committee 
at AIST. 
 
Ⅳ-3 Cardiac differentiation of human MSCs by co-culturing with mouse fetal 
cardiomyocytes 
HEK293FT cells were transiently transfected with an enhanced green 
fluorescent protein (EGFP)-expressing lentivirus vector, CS-RfA-EG (a kind gift from 
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Dr. Miyoshi, Riken) and plasmids encoding gag/pol, rev, and VSV-G (ViraPower 
Lentivirus Expression System, Invitrogen) by using Lipofectamine 2000 (Invitrogen). 
At 72 h post-transfection, the supernatant was filtered through a 0.45-μm filter, and the 
EGFP virus was concentrated using a Lenti-X-concentrator (Clontech). Human MSCs 
were infected with the EGFP lentivirus in the presence of 8 μg/mL of polybrene. Two 
days later, EGFP-expressing MSCs were harvested with 0.25% trypsin and 1 mM 
EDTA and seeded onto the cultured fetal cardiomyocytes at 7 × 10
4
/cm
2
. Every 2 days, 
the culture medium was replaced with fresh culture medium that was supplemented 
with 10% FCS. The morphology of the beating EGFP-labeled MSCs was evaluated 
using a fluorescence microscope. Microscopic images were monitored using an 
Olympus IX70 microscope equipped with CoolSNAP HQ2 (Photometrics), processed 
using MetaMorph software (Molecular Devices), and stored as digital video files. The 
periodical contraction recorded in the video files was further analyzed using Motion 
Analyzer software (Keyence Corp, Japan). The quantification of the contracting 
EGFP-positive human MSCs was performed by counting the beating cardiomyocytes in 
whole wells under a fluorescence microscope. There are many more beating 
GFP-positive cardiomyocytes than shown in our quantified data. However, 
GFP-positive cells that could potentially be pulled by the adjacent mouse 
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cardiomyocytes were not counted. The data were obtained from at least two 
independent experiments. 
 
Ⅳ-4. Immunofluorescence staining 
 Human MSC lines, EPC-214, UE7T-13, UE6E7T-11, UBE6T-15, UE6E7T-12, 
UE7T-9, and UE6E7T-2 were cultured in Lab-Tek Chamber Slides (Nunc). The cells 
were fixed in 4% paraformaldehyde/Tris-buffered saline (TBS), blocked in TBS 
containing 5% donkey serum and 0.25%Tween-20 for 60 min at.room temperature, and 
further incubated overnight at 4 °C with the antibodies against the following proteins: 
N-cadherin (C3865, Sigma, 1:100), α-actinin (A7811, Sigma, 1:100), connexin-43 
(C6219, Sigma, 1:1000), and cardiac troponin T (cTnT; MS-295, NeoMarkers, 1:200). 
These primary antibodies were diluted with TBS containing 5% donkey serum and 
0.25% Tween-20. Subsequently, the cells were washed three times in TBS. 
Alexa594-conjugated secondary antibody was applied to visualize expression of 
specific proteins. The images were obtained using an Olympus IX70 microscope 
equipped with CoolSNAP HQ2 (Photometrics) and processed using MetaMorph 
software (Molecular Devices). Confocal images of the differentiated cells were captured 
sequentially for GFP (excitation: 473 nm, emission range: 490–540 nm) and Alexa 
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Fluor 594 (excitation: 559 nm, emission range: 575–675 nm) using an Olympus 
FluoView FV1000 confocal microscope. After sequential excitation, green and red 
fluorescent images of the same cells were saved and analyzed with FluoView software 
(Ver. 1.7).  
 
Ⅳ-5. Immunoblotting analysis 
 Human mesenchymal stem cell lines, EPC-214, UE7T-13, UE6E7T-11, 
UBE6T-15, UE6E7T-12, UE7T-9, and UE6E7T-2 were homogenized in a buffer 
containing 20 mM Tris-HCl (pH 7.4), 300 mM NaCl, 0.5 mM EDTA, and 1% NP-40, 
and supplemented with complete protease inhibitor cocktail (Roche). After 
centrifugation at 13,000 rpm (13,000g) for 10 min at 4 °C, the supernatant was collected, 
and the protein concentration was determined using the Protein Assay Kit (Bio-Rad). 
Equal amounts of sample were boiled in sample buffer and separated by 5–20% 
SDS-PAGE. The blots were incubated with antibodies against N-cadherin (C3865, 
Sigma, 1:200), Flk1 (10347, IBL, 1:100), c-kit (AF332, R&D Systems, 1:200), 
Integrin-α4 (sc-14008, R&D Systems, 1:200), vascular cell adhesion molecule 1 
(VCAM-1; sc-8304, Santa Cruz, 1:200), Platelet-derived growth factor receptor α 
(PDGFRα; 323503, BioLegend, 1:200), Nkx2.5 (sc-14033, Santa Cruz, 1:200), GATA4 
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(sc-9053, Santa Cruz, 1:200), or β-tubulin (RB-9249, NeoMarkers, 1:1000). Proteins 
were detected using an enhanced chemiluminescence reagent (SuperSignal West Femto 
Maximum Sensitivity Substrate, Pierce) using an LAS-3000 Image Analyzer (Fuji 
Film). 
 
Ⅳ-6. Flow cytometric analysis 
 All of the MSCs cell lines and primary MSCs were harvested with cell 
dissociation buffer (GIBCO) and blocked with normal sheep IgG on ice for 1 h. Cells 
were incubated with biotinylated anti-N-cadherin antibody (BAF1388, R&D System, 
1:100), anti-Flk1 antibody (10347, IBL, 1:100), and allophycocyanin (APC)-conjugated 
anti-c-kit antibody (550412, Becton Dickinson, 1:100) on ice for 1 h. The N-cadherin 
antibody was ﬂuorescent labeled using APC-Alexa Fluor 750 streptavidin (Molecular 
Probes). The Flk1 antibody was ﬂuorescently labeled with Alexa Fluor 488-conjugated 
secondary antibody (Molecular Probes). Cells were resuspended in buffer with 
propidium iodide (PI) (Sigma). Analysis was performed on the FACS Aria (Becton 
Dickinson). Data were re-analyzed by FlowJo software (TOMY Digital Biology, Japan). 
The data was obtained from at least 2 independent experiments. 
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Ⅳ-7. Magnetic cell sorting enrichment of N-cadherin-positive populations 
 Immunomagnetic separation of N-cadherin-positive
 
cells was performed with 
the autoMACS Pro system (Miltenyi Biotec), according to the manufacturer’s 
recommendations. Primary MSCs derived from adipose tissue were dissociated with 
cell dissociation buffer (GIBCO) and blocked with normal sheep IgG. MSCs were 
incubated with biotinylated anti-N-cadherin antibody, followed by incubation with 
streptavidin-APC. Subsequently, cells were incubated with anti-APC microbeads. 
Magnetic cell separation was carried out using the autoMACS Pro separator (Miltenyi 
Biotec) with the Depl025 separation program, according to the recommendations in the 
user’s manual. 
 
Ⅳ-8. DNA microarray analysis 
 Total RNA was isolated from N-cadherin-positive or -negative MSCs using 
ISOGEN (Nippon Gene) according to the manufacturer’s recommendations. 
Fluorescently labeled cRNAs were synthesized using Quick-Amp Labeling Kit 
(Agilent). Labeled cRNAs were hybridized with the 4×44k Whole Human Genome 
oligoMicroarrays (G4122F). The microarray was scanned using a G2505C microarray 
scanner (Agilent), and the result was analyzed with Feature Extraction Software 
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(Agilent). We analyze differences in gene expression among human MSCs and human 
embryonic stem (ES) cells, with GeneSpring GX 11.5.1 software, (Agilent 
Technologies). Data obtained from the gene expression analysis has been deposited in 
GEO (accession number GSE35232). The microarray data of human ES cells (Tesar et 
al., 2007 ) were obtained from GEO data base (GEO accession No. GSE7900). 
 
Ⅳ-9. Quantitative RT-PCR 
 Cardiomyocyte-specific gene expression was examined by quantitative reverse 
transcription (RT)-PCR. Total RNA was extracted from the N-cadherin-positive or 
-negative MSCs by using ISOGEN (Nippon Gene), according to the manufacturer’s 
instructions, and complementary deoxyribonucleic acids (cDNAs) were synthesized 
using PrimeScript Reverse transcriptase (TaKaRa). Primers used for the PCRs are listed 
in Table S1. Real-time PCR reactions were performed using THUNDERBIRD
TM
 SYBR 
qPCR Mix (TOYOBO) with the following program: denaturation at 95 C for 15 s and 
annealing and polymerization at 60 C for 30 s; analysis was performed with the 
Chromo4 system (Bio-Rad). 
 
 
  
19 
 
Ⅳ-10. Statistical analysis  
 All experiments were repeated independently at least twice. Statistical 
significance was determined using a two-tailed Student’s t-test. Differences were 
considered significant at P＜0.05. The Pearson product-moment correlation coefficient 
was used as a measure of strength of the linear association between differentiation 
efficiency and N-cadherin expression. All statistical analysis was performed using the 
data analysis package included in Microsoft Excel 2007 software. 
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Ⅴ. Results 
Ⅴ-1 .Determination of prospective cell surface marker 
Ⅴ-1.1. Efficiency of differentiation of MSC lines into cardiomyocytes 
 MSCs are a mixed cell population of primary adherent cells derived from the 
stroma of various adult tissues, including the bone marrow and adipose tissue. The 
multipotency of MSCs significantly decreases during tissue culture, particularly in high 
serum-containing medium. Therefore, it is not easy to obtain reliable data from these 
heterogeneous MSCs. To overcome these problems, we took advantage of immortalized 
human MSC clones expressing bmi-1, TERT, E6, and/or E7, which retain their 
multipotent differentiation ability over a long time when cultured in vitro (Mori et al., 
2005). Using this method, various immortalized cell lines without chromosomal 
instability, have been established from primary cells. There are several difficulties 
encountered in culturing cells, such as human ovarian surface epithelial cells, 
extravillous trophoblast cells, amnion epithelial cells, endometrial glandular cells, 
hepatocytes, and fibroblasts (Maeda et al., 2005; Omi et al., 2009; Zou et al., 2013; Kyo 
et al., 2003; Tsuruga et al., 2008; Kamada et al., 2012). For the cardiac differentiation of 
human MSCs, a DNA demethylating drug, 5-aza-2'-deoxycitydine has been used 
(Shiota et al, 2007). However, the efficiency of differentiation of MSCs was extremely 
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low (<0.005%). Recent reports also use a co-culture-based method using primary 
cardiomyocytes obtained from mouse embryos or new born mice, which shows much 
better differentiation ability than the former method (Iijima et al., 2003). As for the 
latter method, human MSC cell lines were first labeled with a GFP-expressing lentivirus 
and then cultured on a cardiomyocyte feeder cells prepared from mouse embryonic 
heart tissue (E16.5), as illustrated in Figure 2. Some of the human MSC lines such as 
EPC-214 and UE7T-13 efficiently differentiated into cardiomyocytes. After 5 days of 
culture, a small number of GFP-labeled human MSCs spontaneously began to contract. 
On day 7, 5–10% of these GFP-labeled MSCs differentiated into beating 
cardiomyocytes. GFP-positive, differentiated cardiomyocytes showed autonomously 
periodical contractions (Figure 3). Next, the efficiency of human MSCs differentiation 
into spontaneously beating cardiomyocytes was quantified by counting the number of 
GFP-positive and spontaneously beating cardiomyocytes by using a fluorescence 
microscope on day 7 of differentiation (Figure 4). Immunofluorescence analysis 
confirmed that a significant number of GFP-positive human MSCs expressed various 
terminal differentiation markers, including α-actinin, cardiac troponin T (cTnT), and 
connexin-43 (Cn43), as shown in Figure 5 (left and middle columns). On the other hand, 
some cell lines did not differentiate into beating cardiomyocytes under identical 
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conditions. For example, UE7T-9 cell lines hardly showed periodical contractions and 
rarely expressed the terminal markers of cardiomyocytes (Figure 5, right column). 
  
Ⅴ-1.2. Expression analysis of N-cadherin in MSCs 
The expression of various cell surface proteins, which are essential for the 
development of the heart in vivo or which are specifically expressed in cardiovascular 
progenitor cells, was examined by immunoblotting (Figure 6). Among these markers, 
the expression of N-cadherin showed a relatively good correlation with the efficiency of 
differentiation toward beating cardiomyocytes. The MSC lines highly expressing 
N-cadherin showed a higher capacity for differentiation toward cardiomyocytes. In 
contrast, MSCs that did not readily differentiate into cardiomyocytes expressed low 
levels of N-cadherin. Flk1 has been suggested to be a prospective cell surface marker of 
cardiomyocyte progenitor cells (Kattman et al., 2006; Yamashita et al., 2005). In our 
experiments, Flk1 showed an expression pattern similar to that of N-cadherin. However, 
the expression levels of Flk1 in human MSCs were extremely low. We could not detect 
Flk1 expression after a short exposure time (1 min) of the immunoblotted membrane 
after the enhanced chemiluminescence (ECL) reaction. Only an extremely long 
exposure (30 min) enabled us to detect the Flk1 protein bands in human MSCs (Figure 
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6). The transmembrane tyrosine kinase receptor for stem-cell factor, c-kit, has also been 
reported to be a cell surface marker of the cardiomyogenic progenitor cells in the 
neonatal heart (Tallini et al., 2009). The expression of c-kit showed some correlation 
with the cardiomyogenic differentiation abilities of these cells, although the expression 
levels of c-kit in some human MSCs that readily differentiated into cardiomyocytes 
were very low (Figure 3, UE7T-13, UE6E7T-11, and UBE6T-15). 
Other cell surface proteins have been reported as essential for heart 
development. Integrin α4 is an essential gene for the development of the heart and 
placenta (Yang et al., 1995); a homozygous null mutant of integrin α4 caused embryonic 
lethality due to defects in the epicardium and coronary vessel development, leading to 
cardiac hemorrhage, in addition to failure of fusion between the allantois and chorion 
during placentation. Knockout mice of another cell adhesion molecule, vascular cell 
adhesion molecule 1 (VCAM-1), displayed a reduction in the compact layer of the 
ventricular myocardium and intraventricular septum (Kwee et al., 1995). Pdgfrα is 
expressed in cardiac progenitor cells in the posterior part of the secondary heart field. 
Pdgfrα is also expressed in the valves and pericardia of the heart at E12.5–16.5 
(Takamura et al., 1997). However, the expression of these cell surface proteins did not 
show a strong correlation with the differentiation ability of human MSCs into 
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cardiomyocytes (Figure 4 and 6).  
Next, we further verified the cell surface-specific expression of three candidate 
proteins, namely, N-cadherin, Flk1, and c-kit, in living MSCs by flow cytometry. The 
expression of Flk1 was again barely detectable on the cell surface of human MSCs 
(Figure 7B). In contrast, HUVEC (positive control cells) showed strong cell surface 
expression of Flk1 (Figure 7B, right), indicating that human MSCs do not express 
detectable amounts of Flk1 on the plasma membrane. The cell surface expression of 
c-kit was also relatively low (Figure 7C), and the MSC lines with higher differentiation 
ability toward cardiomyocytes did not show a significant amount of cell surface 
expression of c-kit (Figure 7C, UE7T-13). In contrast, the expression of N-cadherin was 
readily detectable in the human MSC lines with high differentiation ability toward 
beating cardiomyocytes (Figure 7A). When the cell surface expression of N-cadherin 
(Figure 8) and the ability of human MSC cell lines to differentiate into beating 
cardiomyocytes (Figure 4) were carefully compared with human MSC cell lines, a 
strong correlation was observed between these two events (r = 0.81; Figure 9). These 
results suggest that N-cadherin could be a good prospective cell surface marker of 
cardiomyogenic human MSCs. 
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Ⅴ-1.3.Efficiency of differentiation of primary MSCs into beating cardiomyocytes 
and correlation with the expression of N-cadherin 
 Next, we validated the expression of N-cadherin by using various type of 
primary human MSCs, including MSCs derived from bone marrow and adipose tissues, 
as described in Figure 10 - 15. Human bone marrow-derived MSCs (BMSCs) cultured 
for a limited number of passages showed different cell surface expression levels of 
N-cadherin and differentiation abilities to cardiomyocytes, when mouse embryonic 
cardiomyocyte feeder cells were analyzed by the above-mentioned co-culture methods. 
However, a good correlation was observed between the cell surface expression of 
N-cadherin and the ability to differentiate into beating cardiomyocytes (Figure 10 and 
11). Human MSCs derived from adipose tissue (ASCs) also showed results similar to 
those obtained with the BMSCs (Figure 13 and 14). The Pearson's correlation 
coefficients of cell surface expression of N-cadherin and efficiency of differentiation 
into beating cardiomyocytes in BMSCs and ASCs were good in both cases (0.55 and 
0.77, respectively; FIG. 11 and 14). Primary ASCs (Sterneckert et al., 2012) did not 
differentiate into beating cardiomyocytes despite the significant expression of 
N-cadherin. However, the growth of ASCs (Sterneckert et al., 2012) was relatively slow 
and the morphology of the cells were large and flattened compared to other primary 
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ASCs, which suggests unknown deficits of this batch of ASCs. Based on the results 
obtained from primary MSCs, we further confirmed that N-cadherin was a reliable cell 
surface marker for predicting the cardiomyogenic ability of human MSCs obtained from 
bone marrow and adipose tissue. 
 
Ⅴ-2 Magnetic cell sorting based of N-cadherin expression 
Ⅴ-2.1. Demonstration of magnetic cell sorting 
 To determine whether the N-cadherin-positive population of human MSCs had a 
greater ability to differentiate into cardiomyocytes than N-cadherin-negative MSCs, we 
first optimized the separation conditions of N-cadherin-positive cells using magnetic 
cell sorting (MACS). The N-cadherin-positive and highly cardiomyogenic MSC line, 
EPC-214 (Figure 17A), was infected with a GFP-expressing lentivirus and mixed with 
the DDEO-SE-labeled N-cadherin-negative human leukemia cell line, TF-1 (Figure 
17B), to yield a mixed population containing about 20% N-cadherin-positive cells 
(Figure 17C). After purification with anti-N-cadherin antibody-conjugated beads, the 
concentration of N-cadherin-positive EPC-214 cells increased to 91% (Figure 17E), 
demonstrating that our conditions for MACS purification were efficient enough to 
concentrate N-cadherin-positive human MSCs from a mixture.  
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Ⅴ-2.2. Magnetic cell sorting of hMSCs and their differentiation ability 
 Next, the N-cadherin-positive fraction was concentrated from a primary culture of 
human ASCs (1212 used in Figure 13-15) using the same method (Figure 18 and Figure 
18); these cells were further cultured on mouse embryonic heart feeder cells for 7 days. 
As shown in Figure 20, the enriched ASC fraction expressing cell surface N-cadherin 
showed a 4-fold higher cardiomyogenic differentiation capacity than that of the 
N-cadherin-negative fraction. 
 
Ⅴ-2.3. Characterization of N-cadherin positive cells 
 To characterize the cardiomyogenic N-cadherin-positive population, we analyzed the 
gene expression profiles of the MACS-sorted fractions obtained from human MSCs by 
using an Agilent Whole Human Genome array. When the expression of various lineage 
marker genes was compared, the N-cadherin-positive fraction showed up-regulated 
expression of genes involved in the differentiation of cardiomyocytes and skeletal 
myocytes, such as Nkx2.5, Hand1, Tnni3 (cTnI), and Myog (Figure 21). In contrast, 
other lineage markers, including those of ectodermal and endodermal lineages, were the 
same among the MACS-sorted fractions, with the exception of Pax4, a transcription 
factor involved in pancreatic development, which showed higher expression in 
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N-cadherin-positive cells. Although MSCs differentiate into osteoblasts, chondrocytes, 
and adipocytes at higher efficiency, the specific markers of these lineages did not show 
a large marked difference between the N-cadherin-positive and N-cadherin-negative 
fractions. The expression of MSC-specific cell surface markers was also not increased 
in the N-cadherin-positive fraction. 
Next, elevated expression of the cardiomyogenic lineage markers in the 
N-cadherin-positive population was validated by qPCR. A cardiomyogenic 
precursor-specific gene, Nkx2.5, was expressed in the N-cadherin-positive fraction, at 
levels 200-times higher than that in the N-cadherin-negative fraction. Two other 
transcription factors, Hand1 and Gata4, which are involved in cardiomyogenesis, also 
showed significantly elevated expression in the N-cadherin-positive fraction (Figure 22). 
However, the expression of other cardiomyogenic transcription factors such as Tbx5 
was not elevated in N-cadherin-positive cells. Interestingly, the expression of Myog, a 
transcription factor involved in skeletal muscle development, was also elevated in the 
N-cadherin-positive fraction. Although some terminal markers for cardiomyocytes, such 
as ANP and cTnI, showed higher expression in the N-cadherin-positive fraction (Figure 
23), the expression levels of these terminal markers were very low, suggesting that 
N-cadherin-positive cells may be ready for differentiation, but not terminally 
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differentiated into cardiomyocytes. 
Interestingly, the expression of some pluripotency-specific genes such as 
Pou5f1 (Oct4), Sall4, and Nanog was significantly up-regulated in the 
N-cadherin-positive population (Figure 24). These data were confirmed by qPCR 
(Figure 25). Recent studies have suggested that there are at least 2 splice variants of the 
Oct4 gene: Oct4A and Oct4B. Oct4A is highly expressed in ES/iPS cells and regulates 
the pluripotency properties of ES cells, whereas Oct4B, which lacks exon1 but contains 
exon 2a, does not maintain self-renewal in ES cells (Wang et al., 2010). In our 
experiments, N-cadherin-positive cells expressed significantly elevated levels of both 
Oct4A and Oct4B compared to the expression in N-cadherin-negative cells (Figure 25). 
The expression level of Oct4 and Nanog mRNAs in human MSCs was not as high as 
those in human ES cells (Figure 25), suggesting that these genes up-regulated in 
N-cadherin-positive MSCs may not exhibit the pluripotency as observed in ES/iPS cells. 
However, recent reports have suggested that the expression of Oct4 in MSCs is 
correlates with the multiple differentiation abilities of MSCs. For example, 
overexpression of Oct4 enhanced the differentiation ability of MSCs (Liu et al., 2009), 
and knockdown of Oct4 caused loss of multiple differentiation potential (Tsai et al., 
2012). Nanog was also shown to possess similar activity in BMSCs (Go et al., 2008). 
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Therefore, our data suggest that N-cadherin-positive cells with up-regulated expression 
of Oct4 and other transcription factors responsible for cardiomyogenesis could increase 
the ability of MSCs for differentiation into cardiomyocytes. 
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Ⅵ. Discussion  
Among various cell surface markers reported to be essential for heart 
development or to be specific for their expression in cardiovascular tissues, results of 
immunoblotting analysis of various MSC lines identified three candidate markers 
(N-cadherin, Flk1, and c-kit) as prospective cell surface markers of MSCs that have a  
higher cardiomyogenic differentiation capacity. These markers showed some correlation 
between their expression and the efficiency of differentiation of these MSCs into 
beating cardiomyocytes. 
Although Flk1 has been reported to be a cell surface marker for the multipotent 
cardiovascular progenitors observed during the differentiation of human and mouse ES 
cells (Kattman et al., 2006; Yamashita et al., 2005, Yang L et al., 2008). However, the 
cell surface expression level of Flk1 was quite low in human MSCs as analyzed by flow 
cytometry (Figure 7B). Therefore, our results suggest that it is not practical to use Flk1 
as a cell surface marker for human MSCs that have a strong ability to differentiate into 
cardiomyocytes. 
Our immunoblotting analysis also suggested c-kit as a prospective cell surface 
marker for cardiomyogenic human MSCs. Although we observed expression of c-kit in 
the EPC-214 cell line that efficiently differentiated into beating cardiomyocytes in vitro, 
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the cell surface expression of c-kit was not detectable by flow cytometry in the other 
MSC line that readily differentiated into cardiomyocytes (Figure 7C, UE7T-13). These 
results suggested that c-kit is also not a reliable prospective cell surface marker for 
human MSCs with high cardiomyogenic ability. 
In contrast to Flk1 and c-kit, the expression of N-cadherin was much higher, 
and could be reproducibly detected by flow cytometry in MSCs with high 
cardiomyocyte differentiation ability (Figure 4, 7A, 8, 9). There was also a good 
correlation between the N-cadherin expression and cardiomyogenic potential of primary 
human BMSCs and ASCs (Figure 9-14), further indicating that N-cadherin is a good 
prospective cell surface marker for human MSCs having high cardiomyogenic potential. 
In addition, the expression of N-cadherin continues from cardiomyogenic progenitor 
cells to mature cardiomyocytes in the adult heart. N-cadherin maintains the functional 
gap junction complex at the plasma membrane in the adult heart, and conditional 
knockout of N-cadherin in mice resulted in cardiac arrhythmia in adults, with significant 
decreases in Cx43 and Cx40 levels (Li et al, 2005). Based on these observations, 
N-cadherin seems to be a useful and reliable cell surface marker for human MSCs with 
increased capacity for differentiation toward cardiomyocytes. In contrast, cardiac 
differentiated cells from N-cadherin-overexpressing mouse ES cells show good 
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adhesion to cultured cardiomyocytes, (Karabekian et al, 2009). 
We have previously shown that cardiomyogenic progenitor cells differentiated 
from mouse ES cells express high levels of N-cadherin on the surface of the cell 
membrane, and that an antibody against N-cadherin could be used to concentrate the 
progenitor cells from a heterogeneous cell population differentiated from mouse ES 
cells (Honda et al., 2006). Although the possible pathway of differentiation of 
cardiomyocytes from pluripotent ES cells and multipotent MSCs may not be the same, 
N-cadherin could be a common progenitor marker of the cardiomyogenic cells derived 
from these stem cells. 
Purification of N-cadherin-positive cells from primary human MSCs cells with 
anti-N-cadherin-conjugated magnetic beads made it possible to concentrate human 
MSCs with greater ability to differentiate toward cardiomyocytes. Interestingly, the 
purified N-cadherin-positive fraction showed significantly higher expression of several 
cardiomyogenic progenitor cell-specific transcription factors such as Nkx2.5, Hand1, 
and Gata4. Although the overall absolute expression level of cardiomyocyte-specific 
terminal markers was low, some of the cardiomyocyte-specific marker levels were 
higher in the N-cadherin-positive fractions. These results suggest a possible reason for 
the higher potential of N-cadherin-positive MSCs for differentiating into 
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cardiomyocytes.  
In addition to cardiomyogenic genes, we observed increased expression of 
pluripotency-specific transcription factors of ES cells, such as Oct, Sall4, and Nanog, in 
the N-cadherin-positive fraction. Recently, Oct4 was suggested to not simply be a 
reprogramming factor for generating iPS cells nor transcription factor specific for ES 
cells and genital organ, but rather to be the gatekeeper into and out of the 
reprogramming expressway that can be directed by altering experimental conditions 
(Sterneckert et al, 2012). Therefore, the elevated expression of Oct4 and related 
transcription factors could positively modulate the differentiation ability of MSCs.  
Although this study revealed that N-cadherin is a cell surface marker for human 
MSCs that have a strong ability to differentiate into cardiomyocytes, the efficiency of 
differentiation should be improved and the transplant technique should be explored for 
clinical application. Previously some regulatory pathways of cardiomyocyte 
differentiation have shown that Wnt/β-catenin signaling is an important regulator of 
cardiomyocyte differentiation from human ES cells via induction with activin A and 
BMP4 (Paige et al., 2010). Shimoji et al. (2010) screened for humoral factors that 
promote cardiomyocyte differentiation from ES cells, and found that G-CSF is 
significantly involved in cardiomyocyte proliferation. These finding indicate the 
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possibility that the efficiency of differentiation cells into cardiomyocytes will be 
increased by these factors. During the administration of differentiated cardiomyocytes, 
aggregate formation of pluripotent sten cell-derived cardiomyocytes improved their 
survival in the immunodeficient mouse heart because of homophilic cell-cell adhesion 
(Hattori et al., 2010). Recently, cell sheet-based tissue engineering has yielded 
satisfactory therapeutic results in cardiac disease (Haraguchi et al., 2011). The use of a 
cardiogenic cell surface marker, such as N-cadherin, in these methods would facilitate 
their clinical application. 
  
36 
 
Ⅶ. Acknowledgements 
 
First of all, I wish to express my special gratitude to Associate Prof. Akira 
Kurisaki who, with his constructive criticism, enabled me to successfully finish this 
dissertation. 
 
I am grateful to all the members of National Institute of Advanced Industrial Science 
and Technology, Research Center for Stem Cell Engineering for valuable discussions. 
 
I would also like to thank Prof. Jun-Ichi Hayashi, Prof. Kazuto Nakada, and Prof. 
Pi-Chao Wang, Graduate School of Life and Environment Sciences, University of 
Tsukuba for their in valuable advice. 
 
 
  
37 
 
Ⅷ. References 
 
Bolli, R., Chugh, A.R., D’Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., 
Beache, G.M., Wagner, S.G., Leri, A., Hosoda, T., et al. Cardiac stem cells in patients 
with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. 
Lancet 378, 1847–1857. 2011. 
 
Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. Isl1 identifies a cardiac 
progenitor population that proliferates prior to differentiation and contributes a majority 
of cells to the heart. Dev Cell.5:877-89. 2003 
 
Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell.9:11-5. 2011. 
 
Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, 
Lin S, Sun JP. Effect on left ventricular function of intracoronary transplantation of 
autologous bone marrow mesenchymal stem cell in patients with acute myocardial 
infarction. Am J Cardiol.94:92-5. 2004. 
 
  
38 
 
Ema M, Takahashi S, Rossant J. Deletion of the selection cassette, but not cis-acting 
elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent 
mesodermal progenitors. Blood.107:111-7. 2006. 
 
Ferrari SL, Traianedes K, Thorne M, Lafage-Proust MH, Genever P, Cecchini MG, 
Behar V, Bisello A, Chorev M, Rosenblatt M, Suva LJ. A role for N-cadherin in the 
development of the differentiated osteoblastic phenotype. J Bone Miner Res. 
15(2):198-208. 2000. 
 
Go MJ, Takenaka C, Ohgushi H. Forced expression of Sox2 or Nanog in human bone 
marrow derived mesenchymal stem cells maintains their expansion and differentiation 
capabilities. Exp Cell Res.314:1147-54. 2008. 
 
Haraguchi Y, Shimizu T, Yamato M, Okano T. Regenerative Therapies Using Cell 
Sheet-Based Tissue Engineering for Cardiac Disease. Cardiology Research and Practice 
Volume 2011, Article ID 845170, 8 pages. 2011. 
 
Hatta K, Takeichi M. Expression of N-cadherin adhesion molecules associated with 
  
39 
 
early morphogenetic events in chick development. Nature.320:447-449. 1986 
 
Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S, Li W, Yamakawa H, 
Tanaka T, Onitsuka T, Shimoji K, Ohno Y, Egashira T, Kaneda R, Murata M, Hidaka K, 
Morisaki T, Sasaki E, Suzuki T, Sano M, Makino S, Oikawa S, Fukuda K. Nongenetic 
method for purifying stem cell-derived cardiomyocytes. Nat Methods. 7(1):61-6. 2010. 
 
Honda M, Kurisaki A, Ohnuma K, Okochi H, Hamazaki TS, Asashima M. N-cadherin is 
a useful marker for the progenitor of cardiomyocytes differentiated from mouse ES cells 
in serum-free condition. Biochem Biophys Res Commun.351:877-82. 2006. 
 
Iijima Y, Nagai T, Mizukami M, Matsuura K, Ogura T, Wada H, Toko H, Akazawa H, 
Takano H, Nakaya H, Komuro I. Beating is necessary for transdifferentiation of skeletal 
muscle-derived cells into cardiomyocytes. FASEB J. 17(10):1361-3. 2003. 
 
Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, 
Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, 
Urbanek K, Leri A, Anversa P. Bone Marrow Cells Differentiate in Cardiac Cell 
  
40 
 
Lineages After Infarction Independently of Cell Fusion. Circ Res. 96(1):127-37. (2005) 
 
Kamada M, Kumazaki T, Matsuo T, Mitsui Y, Takahashi T. Establishment of ultra 
long-lived cell lines by transfection of TERT into normal human fibroblast TIG-1 and 
their characterization. Cell Biol Int.36:519-27. 2012. 
 
Karabekian Z, Gillum ND, Wong EW, Sarvazyan N. Effects of N-cadherin 
overexpression on the adhesion properties of embryonic stem cells. Cell Adh Migr. 
3(3):305-10. 2009 
 
Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells 
give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev 
Cell.11:723-32. 2006. 
 
Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA. Defective 
development of the embryonic and extraembryonic circulatory systems in vascular cell 
adhesion molecule (VCAM-1) deficient mice. Development.121:489-503. 1995. 
 
  
41 
 
Kyo S, Nakamura M, Kiyono T, Maida Y, Kanaya T, Tanaka M, Yatabe N, Inoue M. 
Successful immortalization of endometrial glandular cells with normal structural and 
functional characteristics. Am J Pathol.163:2259-69. 2003. 
 
Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke 
H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, 
Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic 
stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat 
Biotechnol. (9):1015-24.2007 
 
Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu 
MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR. Postnatal isl1+ cardioblasts 
enter fully differentiated cardiomyocyte lineages. Nature.433:647-53. 2005. 
 
Leobon, B., Garcin, I., Menasche, P., Vilquin, J.T., Audinat, E., and Charpak, S. 
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from 
their host. Proc. Natl. Acad. Sci. 100, 7808–7811. 2003. 
 
  
42 
 
Li J, Patel VV, Kostetskii I, Xiong Y, Chu AF, Jacobson JT, Yu C, Morley GE, 
Molkentin JD, Radice GL. Cardiac-specific loss of N-cadherin leads to alteration in 
connexins with conduction slowing and arrhythmogenesis. Circ Res.97:474-81. 2005. 
 
Li M, Naqvi N, Yahiro E, Liu K, Powell PC, Bradley WE, Martin D.I.K., Graham R.M., 
Dell'Italia L.J., and Husain A. c-kit is required for cardiomyocyte terminal 
differentiation. Circ Res.102:677-85. 2008. 
 
Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. Nkx-2.5: a novel murine 
homeobox gene expressed in early heart progenitor cells and their myogenic 
descendants. Development.119:419-31. 1993. 
 
Liu TM, Wu YN, Guo XM, Hui JH, Lee EH, Lim B. Effects of ectopic Nanog and Oct4 
overexpression on mesenchymal stem cells. Stem Cells Dev.18:1013-22. 2009. 
 
Maeda T, Tashiro H, Katabuchi H, Begum M, Ohtake H, Kiyono T, Okamura H. 
Establishment of an immortalised human ovarian surface epithelial cell line without 
chromosomal instability. Br J Cancer.93:116-23. 2005. 
  
43 
 
Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, 
Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from 
marrow stromal cells in vitro. J Clin Invest.103:697-705. 1999. 
 
Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki 
M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR. Multipotent embryonic 
isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell 
diversification. Cell.127:1151-65. 2006. 
 
Mori T, Kiyono T, Imabayashi H, Takeda Y, Tsuchiya K, Miyoshi S, Makino H, 
Matsumoto K, Saito H, Ogawa S, Sakamoto M, Hata J, Umezawa A. Combination of 
TERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow 
stromal cells from an elderly donor without affecting their neurogenic potential. Mol 
Cell Biol.25:5183-95. 2005. 
 
Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J, 
Fleischmann BK, Jacobsen SE. Bone marrow-derived hematopoietic cells generate 
cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat 
  
44 
 
Med.10:494-501. 2004. 
 
Omi H, Okamoto A, Nikaido T, Urashima M, Kawaguchi R, Umehara N, Sugiura K, 
Saito M, Kiyono T, Tanaka T. Establishment of an immortalized human extravillous 
trophoblast cell line by retroviral infection of E6/E7/TERT and its transcriptional profile 
during hypoxia and reoxygenation. Int J Mol Med.23:229-36. 2009. 
 
Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE. Endogenous 
Wnt/β-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic 
Stem Cells. PLoS ONE 5(6): e11134. 2010 
 
Puch S., Armeanu S., Kibler C., Johnson KR., Müller CA., Wheelock MJ., Klein G.. 
N-cadherin is developmentally regulated and functionally involved in early 
hematopoietic cell differentiation. J. Cell Sci. 114:1567-1577. 2001 
 
Radice GL, Rayburn H, Matsunami H, Knudsen KA, Takeichi M, Hynes RO. 
Developmental defects in mouse embryos lacking N-cadherin. Dev Biol.181:64-78. 
1997. 
  
45 
 
 
Shimoji K, Yuasa S, Onizuka T, Hattori F, Tanaka T, Hara M, Ohno Y, Chen H, Egasgira 
T, Seki T, Yae K, Koshimizu U, Ogawa S, Fukuda K.  G-CSF promotes the 
proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and 
iPSCs. Cell Stem Cell. 6(3): 227-37. (2010) 
 
Shiota M, Heike T, Haruyama M, Baba S, Tsuchiya A, Fujino H, Kobayashi H, Kato T, 
Umeda K, Yoshimoto M, Nakahata T. Isolation and characterization of bone 
marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. 
Exp Cell Res.313:1008-23. 2007. 
 
Sterneckert J, Hoing S, Scholer HR. Concise review: Oct4 and more: the 
reprogramming expressway. Stem Cells.30:15-21. 2012. 
 
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and 
Yamanaka, S. Induction of pluripotent stem cells from adult human ﬁbroblasts by 
deﬁned factors. Cell 131, 861–872. 2007. 
 
  
46 
 
Takakura N, Yoshida H, Ogura Y, Kataoka H, Nishikawa S. PDGFR alpha expression 
during mouse embryogenesis: immunolocalization analyzed by whole-mount 
immunohistostaining using the monoclonal anti-mouse PDGFR alpha antibody APA5. J 
Histochem Cytochem.45:883-93. 1997. Tallini YN, Greene KS, Craven M, Spealman A, 
Breitbach M, Smith J, Patricia J. Fisher
 
P. J., Steffey
 
M, Hesse
 
M,  Robert M. Doran
 
R 
M, Woods
 
A, Singh B, Yen
 
A, Fleischmann
 
BK, Kotlikoff
 
MI. c-kit expression identifies 
cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci U S A.106:1808-13. 
2009. 
 
Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, 
McKay RD. New cell lines from mouse epiblast share defining features with human 
embryonic stem cells. Nature.448:196-9. 2007. 
 
Tsai CC, Su PF, Huang YF, Yew TL, Hung SC. Oct4 and Nanog directly regulate Dnmt1 
to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol 
Cell.47:169-82. 2012. 
 
Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Matsumoto S, Todo S. 
  
47 
 
Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 
and TERT as cell sources for liver cell-based therapy. Cell Transplant.17:1083-94. 2008. 
 
Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow 
mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve.18:1417-26. 1995. 
 
Wang X, Dai J. Concise review: isoforms of OCT4 contribute to the confusing diversity 
in stem cell biology. Stem Cells.28:885-93. 2010. 
 
Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, Orkin SH. 
Developmental origin of a bipotential myocardial and smooth muscle cell precursor in 
the mammalian heart. Cell.127:1137-50. 2006 
 
Yamashita JK, Takano M, Hiraoka-Kanie M, Shimazu C, Peishi Y, Yanagi K, Nakano A, 
Inoue E, Kita F, Nishikawa S. Prospective identification of cardiac progenitors by a 
novel single cell-based cardiomyocyte induction. FASEB J.19:1534-6. 2005 
 
Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by alpha 4 integrins are 
  
48 
 
essential in placental and cardiac development. Development.121:549-60. 1995. 
 
Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, 
Bonham K, Abbott GW, Linden RM. Human cardiovascular progenitor cells develop 
from a KDR+ embryonic-stem-cell-derived population. Nature.453:524-8. 2008. 
 
Zhou K, Koike C, Yoshida T, Okabe M, Fathy M, Kyo S, Kiyono T, Saito S, Nikaido T. 
Establishment and characterization of immortalized human amniotic epithelial cells. 
Cell Reprogram.15:55-67. 2013. 
 
  
49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ⅸ. Table 
 
 
  
50 
 
Table Primers used for qPCR analysis.  
 
Transcript Sequence 
Nkx2.5 F: 5'-CGCCAACAACAACTTCGTGAAC-3' 
  R: 5'-GAGCTGTTGAGGTGGGATC-3' 
Hand1 F: 5'-TTTGTTCTTCGAATCGTGGTG-3' 
  R: 5'-AAAGTGTTTCCCTTGGAACTAA-3' 
GATA4 F: 5'-CACAAGGCTATGCGTCTCC-3' 
  R: 5'-GCCTCCTTCTTTGCTATCCTC-3' 
Tbx5 F: 5'-TAGAGGACATCAGCTGCAACA-3' 
  R: 5'-GGAGAAGTGCTGGTAGGGTA-3' 
ANP F: 5'-AGGGACAGACGTAGGCCAAGAG-3' 
  R: 5'-TCTGGTCTGACCTAGGAGCTGG-3' 
cTnT F: 5'-GGCAGCGGAAGAGGATGCTGAA-3' 
  R: 5'-GAGGCACCAAGTTGGGCATGAACGA-3' 
cTnI F: 5'-TGCAGATTGCAAAGCAAGAG-3' 
  R: 5'-GGTGACTTTTGCCTCTATGTC-3' 
MLC2a F: 5'-GGGAGAAGCTCAATGGGACAG-3' 
  R: 5'-CCACCTCAGCTGGAGAGAAC-3' 
Myog F: 5'-TGTAAGAGGAAGTCGGTGTC-3' 
  R: 5'-CCTCATTCACCTTCTTGAGC-3' 
Oct4 F: 5'-GAGGAAGCTGACAACAATGA-3' 
  R: 5'-TCACTCGGTTCTCGATACTG-3' 
Oct4a F: 5'-TGGAGAGCAACTCCGAT-3' 
  R: 5'-TGCTCCAGCTTCTCCT-3' 
Oct4b F: 5'-AGAGGCACTTCTACAGACTA-3' 
  R: 5'-GAACATAAACACACCAGTTATCAAT-3' 
Nanog F: 5'-AGCTGTGTGTACTCAATGATAG-3' 
  R: 5'-AGGTCTTCACCTGTTTGTAG-3' 
Sall4 F: 5'-GAGAATCCCTGTGACTTTACG-3' 
  R: 5'-GATGACATCATCATGGCAGATAG-3' 
TBP F: 5'-AATCTTGGTTGTAAACTTGACCTA-3' 
  R: 5'-CTTGGGATTATATTCGGCGT-3' 
 
F: forward primer; R: reverse primer. 
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Ⅹ. Figures and Legends 
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Figure 1 Structure of N-cadherin. 
 Schematic diagram showing the structure of the N-cadherin structure. N-cadherin is a type 1 
membrane protein. N-cadherins mediate cell-cell adhesion through homophilic interactions. 
N-cadherin, have distinct expression patterns during embryonic development and in the adult. 
During gastrulation, N-cadherin is expressed in the primitive streak (Hatta K. et al., 1986). 
N-cadherin is also involved in the development of early hematopoietic progenitor cells in the bone 
marrow (Puch S. et al., 2001). During later phase of osteogenic differentiation, N-cadherin is 
expressed in the osteoblasts and contributes to mineralization and nodule formation (Ferrari et al., 
2000). 
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Figure 2 Schematic diagram of the co-culture method for the cardiomyocyte 
differentiation of human mesenchymal stem cells (hMSCs). 
 hMSCs were labeled by infection with GFP-expressing lentivirus, and were then co-cultured on 
fetal mouse cardiomyocytes for 10 days. 
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Figure 3 Periodical contractions of GFP-labeled beating cardiomyocytes derived 
by differentiation of human mesenchymal sten cells (MSCs) for 7 days. 
Lower panel shows the time-dependent distance between points indicated in the upper panel; red 
line: between 0 and 1, blue line: between 2 and 3. 
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Figure 4 Autonomously beating cardiomyocytes differentiated from GFP-labeled 
human mesenchymal stem cell (MSC) lines were counted using a microscope.  
Bar graphs represent the mean value of the differentiation efficiencies obtained from more than two 
independent experiments.  
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Figure 5 Expression of cardiac differentiation markers 
α-actinin (red), cTnT (red), and Cn43 (red), was analyzed by immunofluorescence staining after 
differentiation for 7 days. Human mesenchymal sten cells (MSCs) were labeled with GFP (green). 
Scale bar, 10 μm. 
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Figure 6 The expression of cell surface proteins and transcription factors related to 
cardiovascular development. 
These data were analyzed by immunoblotting of whole cell lysates. 
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Figure 7 Representative FACS plots of cell surface N-cadherin expression in 
human mesenchymal stem cell (MSC) lines. 
The cells were immunostained with (A) N-cadherin, (B) Flk1, or (C) c-kit antibodies. Propidium 
iodide-positive cells were excluded from the analysis.  
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Figure 8 Flow cytometric analysis of cell surface expression of N-cadherin in 
human mesenchymal stem cell (MSC) lines.  
The bar graphs represent the mean value of cell surface protein expression obtained from more than 
two independent experiments. 
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Figure 9 Correlation between the efficiency of differentiation into cardiomyocytes 
and cell surface N-cadherin expression in human mesenchymal sten cell (MSC) 
lines.  
The vertical axis represents the differentiation efficiency, while the horizontal axis represents cell 
surface expression of N-cadherin. The correlation coefficient (r) is shown on the graph. 
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Figure 10 Efficiency of differentiation of primary human bone marrow-derived 
mesenchymal stem cells (BMSCs) into cardiomyocytes. 
In this experiment, primary human mesenchymal stem cells (MSCs) derived from bone marrow 
(BMSCs) were used. Autonomously beating cardiomyocytes differentiated from GFP-labeled human 
BMSCs 
were counted using a microscope. Bar graphs represent the mean values of the differentiation 
efficiencies obtained from more than two independent experiments. 
 
MSC    MSC     ANP      0607         Yub   
36-2    R36-3     0405      NC         623         
2 
1 
0 
  
62 
 
 
 
           
 
 
Figure 11 Cell surface expression of N-cadherin. 
Flow cytometric analysis of cell surface expression of N-cadherin in primary human bone 
marrow-derived mesenchymal stem cells (BMSCs). Bar graphs represent the mean values of 
differentiation efficiency obtained from more than two independent experiments.  
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Figure 12 Correlation between the efficiency of differentiation into beating 
cardiomyocytes and the cell surface N-cadherin expression of primary human bone 
marrow-derived mesenchymal sten cells (BMSCs). 
The vertical axis represents the differentiation efficiency, while the horizontal axis represents cell 
surface expression of N-cadherin. The correlation coefficient (r) is shown on the graph. 
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Figure 13 Efficiency of differentiation of primary human bone marrow-derived 
mesenchymal stem cells (BMSCs) into cardiomyocytes. 
In this experiment, primary human MSCs derived from adipose tissue (ASCs) were used. 
Autonomously beating cardiomyocytes differentiated from GFP-labeled human ASCs were counted 
using a microscope. Bar graphs represent the mean values of the differentiation efficiencies obtained 
from more than two independent experiments. 
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Figure 14 Cell surface expression of N-cadherin. 
Flow cytometric analysis of cell surface expression of N-cadherin in primary human bone 
marrow-derived mesenchymal stem cells (BMSCs). Bar graphs represent the mean values of 
differentiation efficiency obtained from more than 2 independent experiments.  
 
 
8   76  36  1212  NN  1199  MY  1154  55   KN 
2 
1 
0 
3 
4 
5 
  
66 
 
 
 
        
 
 
 
 
Figure 15 Correlation between the efficiency of differentiation into beating 
cardiomyocytes and cell surface N-cadherin expression of primary human adipose 
-derived stem cells (ASCs). 
The vertical axis represents the differentiation efficiency, while the horizontal axis represents cell 
surface expression of N-cadherin. The correlation coefficient (r) is shown on the graph. 
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Figure 16 Schematic diagram of the magnetic cell sorting method 
Human mesenchymal stem cells (hMSCs) were labeled with biotinylated anti-N-cadherin antibody. 
Next, hMSCs were incubated with streptavidin-APC. and anti-APC magnetic beads (A). Cell 
separation was performed on the Auto MACS Pro (B). 
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Figure 17 Demonstration of magnetic cell sorting. 
N-cadherin-positive cells were labeled by infection with GFP-expressing lentivirus (A) and 
N-cadherin-negative cells were labeled with DDAO-SE dye (B). These cells were mixed (C) and 
sorted by using magnetic sorting technique. The N-cadherin-negative fraction contained many 
DDAO-SE-positive cells (D), while the N-cadherin-positive fraction contained many GFP-positive 
cells (E).,  
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Figure 18 Separation of N-cadherin-positive cells obtained from primary 
mesenchymal stem cells (MSCs) derived from adipose tissue with anti-N-cadherin 
antibody-conjugated magnetic beads.  
The FACS histograms represent cell surface N-cadherin expression in the 
N-cadherin-negative fraction (blue) and N-cadherin-positive fraction (orange). 
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Figure 19 Expression of N-cadherin in sorted mesenchymal sten cells (MSCs). 
These data were obtained by western blotting analysis. 
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Figure 20 Efficiency of differentiation of purified primary adipose-derived stem 
cells (ASCs) into beating cardiomyocytes.  
Bar graphs represent the mean value of differentiation efficiency obtained from 2 independent 
experiments. 
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Figur. 21 Characterization of N-cadherin-positive cells derived from adipose tissue 
with anti-N-cadherin antibody-conjugated magnetic beads.  
Heat map profile of lineage-specific differentiation marker expression in adipose-derived stem cells 
(ASCs). The N-cadherin-positive fraction showed elevated expression of specific genes involved in 
cardiomyogenesis 
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Figure 22 Quantitative polymerase chain reaction analysis of cardiomyogenic 
progenitor-specific transcription factors 
White bar represent N-cadherin-negative cells. Black bar represent N-cadherin-positive cells. 
Bar graphs represent the mean values obtained from 2 independent experiments. 
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Figure 23 Quantitative polumerase chain reaction analysis of cardiomyogenic 
terminal differentiation markers 
White bars represent N-cadherin -negative cells. Black bars represent N-cadherin-positive cells. Bar 
graphs represent the mean values obtained from 2 independent experiments. 
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Figure 24 Characterization of N-cadherin-positive cells derived from adipose tissue 
with anti-N-cadherin antibody-conjugated magnetic beads and human embryonic 
stem (ES) cells. 
Heat map profile of pluripotency-specific marker expression in human adipose-derived stem cells 
(ASCs) and human ES cells. 
 
-    + 
N-cadherin 
MSC 
Brix1 
Myc 
Podxl 
Ifitm1 
Klf4 
Nat1 
CD9 
Foxd3 
Utf1 
Grb7 
Dnmt3B 
Oct4 
Sall4 
Nanog 
Gal 
Twert 
Zfp42 
Cdh1 
Fgf4 
Rexo1 
Lefty1 
Tdgf1 
Sox2 
Lefty2 
Dppa4 
Lin28 
Gabrb3 
Gdf3 
Nodal 
color key 
-5.1     0     5.1 
ΔmRNA 
ES01  BG03  H9 
  
76 
 
 
 
 
 
 
 
 
Figure 25 Quantitative polymerase chain reaction analysis of the expression of 
pluripotency-specific transcription factors in MACS-sorted fractions.  
White bars represent N-cadherin-negative cells. Black bars represent N-cadherin-positive cells. Bar 
graphs represent the mean values obtained from 2 independent experiments. 
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